Your browser doesn't support javascript.
loading
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy.
Pérez-Guijarro, Eva; Yang, Howard H; Araya, Romina E; El Meskini, Rajaa; Michael, Helen T; Vodnala, Suman Kumar; Marie, Kerrie L; Smith, Cari; Chin, Sung; Lam, Khiem C; Thorkelsson, Andres; Iacovelli, Anthony J; Kulaga, Alan; Fon, Anyen; Michalowski, Aleksandra M; Hugo, Willy; Lo, Roger S; Restifo, Nicholas P; Sharan, Shyam K; Van Dyke, Terry; Goldszmid, Romina S; Weaver Ohler, Zoe; Lee, Maxwell P; Day, Chi-Ping; Merlino, Glenn.
Affiliation
  • Pérez-Guijarro E; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Yang HH; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Araya RE; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • El Meskini R; Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Michael HT; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Vodnala SK; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Marie KL; Lyell Immunopharma, South San Francisco, CA, USA.
  • Smith C; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Chin S; Laboratory Animal Science Program, Leidos Biomedical Research Inc, Frederick, MD, USA.
  • Lam KC; Laboratory Animal Science Program, Leidos Biomedical Research Inc, Frederick, MD, USA.
  • Thorkelsson A; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Iacovelli AJ; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kulaga A; Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Fon A; Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Michalowski AM; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Hugo W; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lo RS; Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Restifo NP; Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Sharan SK; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Van Dyke T; Lyell Immunopharma, South San Francisco, CA, USA.
  • Goldszmid RS; Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Weaver Ohler Z; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Lee MP; Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
  • Day CP; Path Forward Solutions, Frederick, MD, USA.
  • Merlino G; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Nat Med ; 27(2): 355, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33514948

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2021 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2021 Document type: Article Affiliation country: Estados Unidos